These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19372219)

  • 41. Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.
    Bolger GB; Dunlop AJ; Meng D; Day JP; Klussmann E; Baillie GS; Adams DR; Houslay MD
    Cell Signal; 2015 Apr; 27(4):756-69. PubMed ID: 25546709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
    Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination.
    Ahmed MR; Zhan X; Song X; Kook S; Gurevich VV; Gurevich EV
    Biochemistry; 2011 May; 50(18):3749-63. PubMed ID: 21466165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
    Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
    Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.
    Bjørgo E; Solheim SA; Abrahamsen H; Baillie GS; Brown KM; Berge T; Okkenhaug K; Houslay MD; Taskén K
    Mol Cell Biol; 2010 Apr; 30(7):1660-72. PubMed ID: 20086095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cyclic AMP phosphodiesterase 4D5 (PDE4D5)/receptor for activated C-kinase 1 (RACK1) signalling complex as a sensor of the extracellular nano-environment.
    Yarwood SJ; Parnell E; Bird RJ
    Cell Signal; 2017 Jul; 35():282-289. PubMed ID: 28069443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GRK2-mediated receptor phosphorylation and Mdm2-mediated β-arrestin2 ubiquitination drive clathrin-mediated endocytosis of G protein-coupled receptors.
    Zhang X; Zheng M; Kim KM
    Biochem Biophys Res Commun; 2020 Dec; 533(3):383-390. PubMed ID: 32962859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.
    Perry SJ; Baillie GS; Kohout TA; McPhee I; Magiera MM; Ang KL; Miller WE; McLean AJ; Conti M; Houslay MD; Lefkowitz RJ
    Science; 2002 Oct; 298(5594):834-6. PubMed ID: 12399592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arrestin-dependent localization of phosphodiesterases.
    Willis MJ; Baillie GS
    Handb Exp Pharmacol; 2014; 219():293-307. PubMed ID: 24292836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity.
    Serrels B; Sandilands E; Serrels A; Baillie G; Houslay MD; Brunton VG; Canel M; Machesky LM; Anderson KI; Frame MC
    Curr Biol; 2010 Jun; 20(12):1086-92. PubMed ID: 20493699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5.
    Steele MR; McCahill A; Thompson DS; MacKenzie C; Isaacs NW; Houslay MD; Bolger GB
    Cell Signal; 2001 Jul; 13(7):507-13. PubMed ID: 11516626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2.
    Salcedo A; Mayor F; Penela P
    EMBO J; 2006 Oct; 25(20):4752-62. PubMed ID: 17006543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins.
    Skieterska K; Shen A; Clarisse D; Rondou P; Borroto-Escuela DO; Lintermans B; Fuxe K; Xiang YK; Van Craenenbroeck K
    Cell Signal; 2016 Aug; 28(8):1001-14. PubMed ID: 27155323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitization in airway smooth muscle.
    Nino G; Hu A; Grunstein JS; Grunstein MM
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L746-57. PubMed ID: 19666775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.
    Murthy KS; Sriwai W
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G327-35. PubMed ID: 18006600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.
    Hara MR; Kovacs JJ; Whalen EJ; Rajagopal S; Strachan RT; Grant W; Towers AJ; Williams B; Lam CM; Xiao K; Shenoy SK; Gregory SG; Ahn S; Duckett DR; Lefkowitz RJ
    Nature; 2011 Aug; 477(7364):349-53. PubMed ID: 21857681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4.
    Shukla AK; Kim J; Ahn S; Xiao K; Shenoy SK; Liedtke W; Lefkowitz RJ
    J Biol Chem; 2010 Sep; 285(39):30115-25. PubMed ID: 20650893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin.
    Laporte SA; Miller WE; Kim KM; Caron MG
    J Biol Chem; 2002 Mar; 277(11):9247-54. PubMed ID: 11777907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.
    De Arcangelis V; Liu R; Soto D; Xiang Y
    J Biol Chem; 2009 Dec; 284(49):33824-32. PubMed ID: 19801680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.